| Vol. 12.33 – 24 August, 2023 |
| |
|
|
| Using a CRISPR-based autochthonous SCLC genetically engineered mouse model to study the consequences of KDM6A/UTX inactivation, investigators showed that KDM6A inactivation induced plasticity from ASCL1 to NEUROD1 resulting in SCLC tumors that expressed both ASCL1 and NEUROD1. [Nature Cell Biology] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists analyzed the efficiency of 3D spheroids combined with a minimally modified graphene oxide-based nanocarrier for siRNA delivery as a new system for cell transfection. [Biomaterials Science] |
|
|
|
| Researchers elucidated the contribution of the axis of 27-hydroxycholesterol derived from sterol 27-hydroxylase (CYP27A1) to the pathophysiology of asthma. House dust mite extract was intranasally administered to C57BL/6 mice and the expression of CYP27A1 in the airways was analyzed by immunostaining. [Allergology International] |
|
|
|
| Scientists established models of pulmonary fibrosis (PF) including a mouse model stimulated by bleomycin and a HFL1 cell model induced by transforming growth factor-β1 to evaluate the inhibition effects of Schisandrin C on PF. [Scientific Reports] |
|
|
|
| Investigators explored their roles and underlying mechanisms in sepsis. The amounts of Th17 cells, IL-17A, IL-1β, IL-18, and lipopolysaccharide was significantly elevated in sepsis patients. [Advanced Biology] |
| |
|
|
| Scientists constructed a new albumin-encapsulated platinum (Pt) (IV) nanodrug (HSA@Pt(IV)) based on the Pt(IV) drug and nanodelivery system. The characterization of nanodrug and biological experiments demonstrated its excellent drug delivery and antitumor effects. [Small] |
|
|
|
| Investigators identified Cezanne, a member of the ovarian tumor protease-deubiquitinating family, as an autophagy regulator. Cezanne was highly expressed in Osimertinib-resistant cells, and Cezanne overexpression promoted Osimertinib resistance, while chloroquine, an autophagy inhibitor, reverted this process. [Cell Death Discovery] |
|
|
|
| Scientists assessed the biological and clinical significance of TROAP in NSCLC. RT-qPCR, western bolt, and immunohistochemistry assay were used to test TROAP RNA and protein expression not in lung adenocarcinoma (LUAD) tissues and paraneoplastic tissues but in LUAD cell lines and control cell lines. [Medical Oncology] |
|
|
|
| Researchers investigated how testis expressed 19 (TEX19) works exactly in lung adenocarcinoma (LUAD). Real-time quantitative PCR assay showed that TEX19 was significantly overexpressed in LUAD cell lines compared with normal bronchial epithelial cells BEAS-2B. [Molecular Biotechnology] |
|
|
|
|
| The authors present the findings from research on respiratory diseases that have utilized systems targeting senescent cells and to identify potential therapeutic strategies for the clinical management of chronic pulmonary conditions. [Geriatrics & Gerontology International] |
|
|
|
|
| Roche announced that it was made aware of an inadvertent disclosure of the second interim analysis of the Phase III SKYSCRAPER-01 study, evaluating the investigational anti-TIGIT immunotherapy tiragolumab plus Tecentriq® versus Tecentriq alone as an initial treatment for people with PD-L1-high locally advanced or metastatic NSCLC. [Roche] |
|
|
|
|
| September 14, 2023 Seogwipo, South Korea |
|
|
|
|
|
| National Institutes of Health – Bethesda, Maryland, United States |
|
|
|
| Columbia University Irving Medical Center – New York City, New York, United States |
|
|
|
| University of Washington – Medical Lake, Washington, United States |
|
|
|
| Creative Biolabs – New York, New York, United States |
|
|
|
| University of Giessen – Giessen, Germany |
|
|
|
|